These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29305845)

  • 21. Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease.
    Chung GE; Yim JY; Kim D; Kwak MS; Yang JI; Chung SJ; Yang SY; Kim JS
    Dig Liver Dis; 2017 Jan; 49(1):57-62. PubMed ID: 27810399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study.
    Yang J; Zhou W; Wu Y; Xu L; Wang Y; Xu Z; Yang Y
    J Int Med Res; 2020 Aug; 48(8):300060520935219. PubMed ID: 32762395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study.
    Park HE; Kwak MS; Kim D; Kim MK; Cha MJ; Choi SY
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3134-43. PubMed ID: 27253666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
    Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Plasma C1q/TNF-Related Protein 3 (CTRP3) in Patients with Atrial Fibrillation.
    Chen L; Liu S; Xu W; Zhang Y; Bai J; Li L; Cui M; Sun L
    Mediators Inflamm; 2020; 2020():8873152. PubMed ID: 33424438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output.
    Peterson JM; Wei Z; Wong GW
    J Biol Chem; 2010 Dec; 285(51):39691-701. PubMed ID: 20952387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.
    Zhang H; Niu Y; Gu H; Lu S; Zhang W; Li X; Yang Z; Qin L; Su Q
    J Clin Lab Anal; 2019 Mar; 33(3):e22709. PubMed ID: 30390352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Serum Sialic Acid Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
    He J; Mao W; Zhang J; Jin X
    Ann Nutr Metab; 2015; 67(2):69-75. PubMed ID: 26315777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
    J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease is not associated with a lower health perception.
    Mlynarsky L; Schlesinger D; Lotan R; Webb M; Halpern Z; Santo E; Shibolet O; Zelber-Sagi S
    World J Gastroenterol; 2016 May; 22(17):4362-72. PubMed ID: 27158205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement c1q tumor necrosis factor-related protein 3 a novel adipokine, protect against diabetes mellitus in young adult Egyptians.
    Elsaid HH; Elgohary MN; Elshabrawy AM
    Diabetes Metab Syndr; 2019; 13(1):434-438. PubMed ID: 30641739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
    Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S
    PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Bano A; Chaker L; Plompen EP; Hofman A; Dehghan A; Franco OH; Janssen HL; Darwish Murad S; Peeters RP
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3204-11. PubMed ID: 27270473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
    Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
    Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.